Funding for innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, and other research on lung cancer.

LCRF grants are awarded for projects focused on one or more of the following areas of lung cancer research

Lung cancer biology

Prevention and screening for early detection

Identification of new biomarkersDevelopment of more effective and less toxic therapies including but not limited to targeted and immune-therapies

Mechanisms of sensitivity and resistance to lung cancer therapies

Supportive measures for people with lung cancer and their families

Quality of care and outcomes research

Duration 

2 years

Funding

$150,000 for a period of two years (disbursed at $75,000 per year)

Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years' experience since their initial faculty appointment.

Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.

Senior investigators with more than ten years' experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years' experience in other disease areas or topics. Ineligible investigators with these or other special circumstances may request review by contacting the LCRF grants office.

All applications must be submitted through LCRF's online grants management system: https://lcrf.org/grantinterface

Previews of the LOI and full application may be accessed at http://lcrf.org/application_preview

Applications must be submitted through a two-stage process:

A letter of intent (LOI): deadline April 30th

A full proposal(under invitation); deadline August 27^th

In case of interest, contact with FSJD Research Department